← Open Payments lookup

MARCO PAOLO DELMONTE: Open Payments

NPI 1902677974 · MENIFEE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$581 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $100 · 2025 $581

Food & beverage: $581
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$193
Otsuka America Pharmaceutical, Inc.3$76
Vanda Pharmaceuticals Inc.3$69
Teva Pharmaceuticals USA, Inc.2$63
ABBVIE INC.2$41
Janssen Pharmaceuticals, Inc1$33
Luye Pharma (USA) Ltd.1$23
Axsome Therapeutics, Inc.1$23
Neos Therapeutics, LP1$20
E.R. Squibb & Sons, L.L.C.1$20

Products named: CAPLYTA, REXULTI, FANAPT, AUSTEDO XR, VRAYLAR, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, Auvelity.

Industry payments across CA — which companies pay providers there.